Mumbai, Sept. 15 -- Mumbai, September 15, 2026: Tavexia Lifecare Limited (formerly Sattva Sukun Lifecare Limited) (BSE: 539519) Tavexia the Company today announced a series of strategic and governance decisions taken by its Board of Directors at its meeting held on September 7, 2026.
As part of its expansion into pharmaceutical manufacturing, the Board has considered a proposal to acquire up to 60% of Meyonex Pharmaceuticals Limited, an unlisted pharmaceutical manufacturing company based in Tarapur, Palghar, Maharashtra. The Board has authorised Mr. Chirag Deepak Dedhia and Mr. Sachin Bhanubhai Manseta, Directors of Tavexia, to lead preliminary discussions, due diligence, valuation and negotiations. The proposed transaction remains subject...